P092 Efficacy and tolerability of dornase alfa biosimilar in children and adults with cystic fibrosis.

Autor: Shadrina, V.^1,2 (AUTHOR), Kondratyeva, E.^1,3 (AUTHOR), Voronkova, A.^1,3 (AUTHOR), Zhekaite, E.^1,3 (AUTHOR), Krasovskiy, S.^1,4 (AUTHOR), Amelina, E.^1,4 (AUTHOR), Orlov, A.⁵ (AUTHOR), Pinegina, J.⁶ (AUTHOR), Lavrova, A.⁷ (AUTHOR), Trishina, S.⁸ (AUTHOR), Abdulganieva, D.⁹ (AUTHOR), Semykin, S.¹⁰ (AUTHOR), Vlasova, A.¹¹ (AUTHOR)

Publikováno v: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS95-S95. 1p.